INFECTIOUS CONTROL FOR MYOBACTERIUM TUBERCULOSIS Author Policy Ratified by Committee Date Classification OSHEU Date Issued Area Applicable University Wide Review Date Ref No: Version No: 15/02/05 1 Disclaimer When using this document please ensure that the version you are using is the most up-to-date. Occupational Safety, Health and Environment Unit/Updated July 2004/TBPol 1 Mycobacterium tuberculosis policy/I:winword.policies.tuberculosis.tbpol2001.doc/01.02/ipcd.dwh IPCD Policy Number 7 CARDIFF AND VALE NHS TRUST YMDDIRIEDOLAETH GIG CAERDYDD A’R FRO H/8 Policy on Infection Control for Mycobacterium Tuberculosis This policy was approved by Cardiff and Vale NHS Trust Board April 2002 Date of review – April 2004 Central Registration Number – If the date at the time of reference to this Policy document is after the stated date for review you must contact the author, or if absent, the Corporate Affairs Director, to check that the content is current. Out of date policies must not be relied on Occupational Safety, Health and Environment Unit/Updated July 2004/TBPol 2 Mycobacterium tuberculosis policy/I:winword.policies.tuberculosis.tbpol2001.doc/01.02/ipcd.dwh Contents Page 1 2 3 4 5 6 7 Summary Introduction Notification of Tuberculosis Ward Procedures 4.1 Confirmed or suspected smear positive pulmonary disease 4.2 Multiple drug resistant tuberculosis (MDR-TB) 4.3 Confirmed smear negative pulmonary disease 4.4 Non-pulmonary disease 4.5 Infants born to mothers with infectious tuberculosis Transfer of Patients 5.1 Within the hospital 5.2 Visits to other departments and surgical operations 5.3 Transfer to other hospitals 5.4 Ambulance transportation Health Care Personnel 6.1 Pre-employment 6.2 Routine screening 6.3 Contacts of smear positive pulmonary tuberculosis 6.4 Contacts of smear negative or non-pulmonary tuberculosis References Occupational Safety, Health and Environment Unit/Updated July 2004/TBPol 4 4 4 5 7 7 9 3 Mycobacterium tuberculosis policy/I:winword.policies.tuberculosis.tbpol2001.doc/01.02/ipcd.dwh 1. Summary All forms of tuberculosis are notifiable to the Consultant in Communicable Disease Control by the doctor making or suspecting the diagnosis. Notify the Infection Prevention and Control Department. Adult patients with smear positive pulmonary disease should be transferred to a negative pressure room on the Infectious Disease Unit whenever possible. Respiratory isolation should be for two weeks after commencement of treatment for drug susceptible tuberculosis. Additional control measures are required for suspected or confirmed Multiple Drug Resistant Tuberculosis. MDR-TB patients should be transferred to the Infectious Disease Unit. Staff and visitors entering the room should wear specialised TB masks. Smear negative pulmonary patients can be nursed on open ward unless there are immunocompromised patients present. Non-pulmonary Tuberculosis may be nursed on an open ward. All new staff members including students and locums must have their Tuberculosis status established by Occupational Health. Follow up of staff contacts of smear positive pulmonary tuberculosis cases will be carried out by Occupational Health. 2. Introduction The Joint Tuberculosis Committee of the British Thoracic Society produced an updated Code of Practice for the Control and Prevention of Tuberculosis in the United Kingdom in 20001. This Code of Practice takes into account evidence in relation to control of infection in hospitals, protection of health care workers, contact tracing, multidrug-resistant disease and the possible effects of HIV on tuberculosis. In 1998 the Interdepartmental Working Group on Tuberculosis produced guidance on the control and transmission of HIV related tuberculosis and multiple drug resistant tuberculosis2. The guidance given in this document is taken from these two Codes of Practice. Since the publication of the previous British Thoracic Society guidelines in 1994 the epidemiology of tuberculosis in Britain has continued to change with increases in the number of notifications, mostly in large urban areas. While the rates of tuberculosis in HIV cases has continued to rise the rate for drug resistant tuberculosis has not risen but resistance remains an important issue. All forms of tuberculosis are notifiable to the Consultant in Communicable Disease Control. This allows data collection to monitor epidemiological trends and to initiate appropriate contact tracing. Failure to notify may mean that close contacts are not screened and may result in appropriate chemoprophylaxis or BCG vaccination not being given. Notification must be on first awareness/suspicion of the possibility of tuberculosis. Failure to comply can result in prosecution by the public health authority against the responsible clinicians and the Trust. 3. Notification of Tuberculosis All forms of tuberculosis are notifiable to the Consultant in Communicable Disease Control (CCDC) by the doctor making or suspecting the diagnosis. This must be done initially by phone (Cardiff 20 402478) and then by the official notification form. Failure to notify in some circumstances could lead to action for medical negligence. Occupational Safety, Health and Environment Unit/Updated July 2004/TBPol 4 Mycobacterium tuberculosis policy/I:winword.policies.tuberculosis.tbpol2001.doc/01.02/ipcd.dwh The Infection Prevention and Control Department must also be notified by phone (see Section 1). This will ensure that the appropriate infection control procedures are implemented at ward level. Contact tracing and screening of staff members may occasionally be necessary and when required will be done in conjunction with local Public Health Officers and UHW Occupational Health Department. 4. Ward Procedures The method of isolation/precautions used for patients with tuberculosis depends on the type of disease diagnosed. 4.1 Confirmed or Suspected Smear Positive Pulmonary Disease Patients with smear positive pulmonary disease require isolation in a room ventilated to the outside or with mechanical ventilation extract system. Therefore, whenever possible, patients with such disease should be transferred to the Infectious Diseases Unit (ward A7, U.H.W.) for isolation and treatment. Isolation should be for a period of two weeks after the commencement of treatment for drug susceptible tuberculosis. Crockery and cutlery can be treated as for any other patient and no extra precautions are required for linen etc. Infected material and other clinical waste should be disposed of by incineration, in the usual manner. If a patient on a general ward is diagnosed as having infectious tuberculosis after having been there for several days the Infection Control Team should be contacted to make an assessment of risk to other patients. Other patients must have their exposure documented and the Consultant in Communicable Disease Control informed (CCDC). a. Visitors All visitors must report to the nurse-in-charge of the ward. Only visitors that have been in close contact with the patient before diagnosis was made should be allowed to visit; however individual risk assessments on potentially infective or susceptible visitors must be made. Visitors of children with tuberculosis should be segregated from the rest of the ward until they have been screened to exclude them as a source of infection. b. Cleaning Housekeepers cleaning the room are not at particular risk but should have had their BCG/immune status established. Normal housekeeping procedures should be carried out. Including terminal cleaning on discharge of the patient; see Cardiff and Vale Decontamination Policy 2001. c. Isolation Transfer/admission to the Infectious Diseases Unit (A7, UHW) should be considered in these cases. A single room should be used, if one is not available contact the IPCT. Visitors and members of staff from other departments must report to the Nurse-inCharge before entering the room. Patients should not leave the room to attend other departments without prior arrangements. A respiratory isolation sign (pink) should be displayed on the door. The door of the room should be kept closed at all times unless the clinical need of the patient dictates otherwise. Gloves should be worn if there is any risk from contamination with blood and body fluids. Occupational Safety, Health and Environment Unit/Updated July 2004/TBPol 5 Mycobacterium tuberculosis policy/I:winword.policies.tuberculosis.tbpol2001.doc/01.02/ipcd.dwh Plastic aprons must be worn when soiling is likely. Those who come into close contact with the patient should wear masks. Specialist masks for tuberculosis should be used for contact with cases of smear positive TB. (see below). Face protection, e.g. visor, goggles or fluid shield face mask should be worn if there is a risk of splashing from blood or body fluids and secretions. Hands must be washed with soap and water and then disinfected with an approved hand disinfectant (e.g. alcohol gel) before entering the room, after patient contact, after contact with potentially infected materials, and after removal of disposable gloves. 4.2 Multiple Drug Resistant Tuberculosis (MDR-TB) Additional infection control procedures for patients with multiple drug resistance will be decided by risk assessment on the units treating the patient. Whenever possible patients with suspected or confirmed multiple drug resistant tuberculosis should be transferred to the Infectious Diseases Unit (UHW). Staff and visitors entering the room of a confirmed or suspected case of MDR-TB should wear a specialised mask. The recommended mask for use in the Trust is the Tecnol PFR95 (ref no. 46727). The patient should remain in isolation in a negative pressure room until assessed to be non-infectious which ideally should be: the patient has had a minimum of two weeks of appropriate therapy and three negative sputum microscopic smears on three separate occasions over at least a fourteen day period and shown tolerance to the prescribed treatment and ability and agreement to adhere to treatment and either a complete resolution of cough or definite clinical improvement to treatment. 4.3 Confirmed Smear Negative Pulmonary Disease The patient may be nursed on the open ward unless there are immunocomprimised patients on the same ward in which case the patient should be placed in a side room. If aerosol-generating procedures are to be performed (e.g. bronchoscopy) the patient should be isolated during the procedure. 4.4 Non-Pulmonary Tuberculosis The patient may be nursed on the open ward although aerosol-generating procedures (e.g. abscess or wound irrigation) may necessitate patient isolation. 4.5 Infants Born to Mothers With Infectious Tuberculosis Infants born to mothers who have infectious TB should receive chemoprophylaxis for six weeks and then be tuberculin tested, if negative BCG must be given, if positive the chemoprophylaxis should be continued. Specialist advice should be sought before starting treatment. Occupational Safety, Health and Environment Unit/Updated July 2004/TBPol 6 Mycobacterium tuberculosis policy/I:winword.policies.tuberculosis.tbpol2001.doc/01.02/ipcd.dwh 5. Transfer of Patients As with other Infection Control matters, the Nurse-in-charge of the ward has the responsibility to ensure that the necessary information regarding an infectious patient is passed on to a senior member of the receiving ward/department, prior to transfer. 5.1 Within the Hospital Patients with smear negative pulmonary and non-pulmonary tuberculosis do not present a problem for the receiving ward. When transfers of this type take place the receiving ward must be informed of the patient’s current status prior to transfer. Smear positive pulmonary tuberculosis patients should be transferred, whenever possible, to the Infectious Diseases Unit and should only be discharged from this unit to another ward in the hospital when the consultant-in-charge of the patient is satisfied that they are no longer infectious. Immediate clinical need may occasionally necessitate patient movement outside the Infectious Diseases Unit; advice is available from the Infection Prevention and Control Department. 5.2 Visits to Other Departments and Surgical Operations Visits of smear-negative pulmonary and non-pulmonary tuberculosis cases to other departments should be kept to a minimum. When there is a need arrangements must be made with the senior staff of the department concerned prior to transfer. Patients should be seen at the end of the working session and should spend the minimum time in the department. Patients with smear-positive pulmonary tuberculosis must not visit other departments, unless there is an important clinical need. If they do need to visit another department the patient should wear a TB protective mask (see section 4.2). Patients requiring a visit to the operating theatre must be regarded as infectious and treated in accordingly. 5.3 Transfer to Other Hospitals Smear positive pulmonary tuberculosis patients should only be transferred to units that have ventilated rooms unless the consultant-in-charge of the patient is satisfied they are no longer infectious. Prior arrangements will have to be made with the receiving ward and the ambulance service for transfer of an infectious patient. No transfer should take place unless all parties, especially in the case of MDR-TB, have agreed these arrangements. The receiving ward must be informed of the current status of the patient. For smear-negative or non-pulmonary tuberculosis transfer can take place much more readily; but the receiving ward must be notified of the patients status prior to transfer. 5.4 Ambulance Transportation The ambulance service must be notified prior to transfer of smear positive pulmonary patients especially MDR-TB. Further information for the ambulance service can be obtained from the Consultant in Communicable Disease Control (CCDC 029 20 402478). 6. Health Care Personnel 6.1 Pre-Employment All new staff members including locums and students will be questioned by Occupational Health to establish whether they have symptoms suggestive of tuberculosis. They will also be required to show evidence of a BCG scar. Those without a definite scar must be Heaf tested. Occupational Safety, Health and Environment Unit/Updated July 2004/TBPol 7 Mycobacterium tuberculosis policy/I:winword.policies.tuberculosis.tbpol2001.doc/01.02/ipcd.dwh Individuals with a negative or grade 1 reaction must receive BCG vaccination. The site of vaccination should be inspected six weeks later. Those without a satisfactory reaction must receive a further tuberculin test and if necessary a second BCG. Staff members with suspicious symptoms will require chest radiography and clinical assessment as directed by the Consultant Occupational Health Physician. Asymptomatic individuals with grade 2, 3 or 4 Heaf tests do not require vaccination. However a new staff member that comes from a geographical location where tuberculosis is endemic must undergo clinical and radiographic examination as directed by the Consultant Occupational Health Physician. 6.2 Routine Screening Routine chest radiography is not required for any group of hospital staff. 6.3 Contacts of Smear Positive Pulmonary Tuberculosis Initially a list of all staff members that have had contact with the infectious index patient will be made. The Infection Prevention and Control Department and senior ward staff will do this. The contact list will then be forwarded to the Occupational Health Department, and to the Consultant in Communicable Disease Control. Close contacts are defined as members of staff who carry out: mouth-to-mouth resuscitation prolonged care of a high dependency patient repeated chest physiotherapy Close contacts will be notified to Occupational Health Department for Heaf testing and follow up as directed by the Consultant Occupational Health Physician. Casual contacts should only be examined if they are unusually susceptible or if they have no history of BCG. They should be given a Heaf test and BCG if necessary. 6.4 Contacts of Smear Negative or Non-Pulmonary Tuberculosis In these cases no action is necessary. Occupational Safety, Health and Environment Unit/Updated July 2004/TBPol 8 Mycobacterium tuberculosis policy/I:winword.policies.tuberculosis.tbpol2001.doc/01.02/ipcd.dwh 7. References 2. The Prevention and Control of Tuberculosis in the United Kingdom: UK Guidance on the Prevention and Control of Transmission of: 1. HIV-related Tuberculosis, 2. Drug – resistant Including Multiple Drug – resistant, Tuberculosis. The Interdepartmental Working Group on Tuberculosis (1998) Department of Health. 1. Control and Prevention of tuberculosis in the United Kingdom: Code of Practice 2000. Joint Tuberculosis Committee of the British Thoracic Society. Thorax 2000; 55: 887 - 901 Occupational Safety, Health and Environment Unit/Updated July 2004/TBPol 9